|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,742.00 MXN | +0.62% |
|
+0.62% | +9.68% |
| 07-13 | Novartis' Vanrafia Wins Health Canada Approval for IgA Nephropathy | MT |
| 07-13 | Wall Street's Stress Test Arrives |  |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- NVS N Stock
- Charts Novartis AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
